Stockreport

Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF Open-label portion of the pivotal Phase 3 CYPRESS study of ampreloxetine now complete; topline readout on track for Q1 2026 Company to host an ampreloxetine focused v [Read more]